InsiderClue
← All stocks

Braveheart Bio, Inc.

BRVE Net buying
CIK 0002131524 #2086 in the set updated 17 Sep 2026
Bought (12 mo)
$159.03M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$159.03M
+$159.03M against sales at will

By person

11 insiders · 13 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Forbion Growth Opportunities Fund III Cooperatief U.A. entity
10% owner
$64.80M (2)
—
+$64.80M
21,826,024
$392.87M
+1,879%
Chimovits Erez
Director
$34.92M (2)
—
+$34.92M
273,333
$4.92M
—
ORBIMED ADVISORS LLC entity
Director
$34.92M (2)
—
+$34.92M
273,333
$4.92M
—
AH Bio Fund IV, L.P. entity
10% owner
$19.80M (1)
—
+$19.80M
10,232,420
$184.18M
—
Murdoch Travis
CEO and President
$1.50M (1)
—
+$1.50M
2,940,670
$52.93M
+2.9%
Viehbacher Christopher
Director
$1.50M (1)
—
+$1.50M
609,519
$10.97M
+15.8%
Lubner David Charles
Director
$999.99K (1)
—
+$999.99K
55,555
$999.99K
—
Rickey James Paul
Chief Financial Officer
$499.99K (1)
—
+$499.99K
520,927
$9.38M
+5.6%
Malek David I
Director
$74.99K (1)
—
+$74.99K
533,845
$9.61M
+0.8%
Anderson Michele A.
Chief Development Officer
$20.00K (1)
—
+$20.00K
332,161
$5.98M
+0.3%
Jiangsu Hengrui Pharmaceuticals Co., Ltd. entity
10% owner
—
—
—
7,420,091
$133.56M
—

No percentages here. Braveheart Bio, Inc. reports its share count only per share class, which the XBRL frames API does not carry.

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Lubner David Charles
7 Aug 2026
Director
Buy
55,555
$18.00
$999.99K
Murdoch Travis
7 Aug 2026
CEO and President
Buy
83,333
$18.00
$1.50M
Anderson Michele A.
7 Aug 2026
Chief Development Officer
Buy
1,111
$18.00
$20.00K
Malek David I
7 Aug 2026
Director
Buy
4,166
$18.00
$74.99K
Viehbacher Christopher
7 Aug 2026
Director
Buy
83,333
$18.00
$1.50M
Rickey James Paul
7 Aug 2026
Chief Financial Officer
Buy
27,777
$18.00
$499.99K
Forbion Growth Opportunities Fund III Cooperatief U.A.
7 Aug 2026
10% owner
Buy indirect
1,680,000
$18.00
$30.24M
Forbion Growth Opportunities Fund III Cooperatief U.A.
7 Aug 2026
10% owner
Buy
1,920,000
$18.00
$34.56M
ORBIMED ADVISORS LLC
7 Aug 2026
Director
Buy indirect
273,333
$18.00
$4.92M
ORBIMED ADVISORS LLC
7 Aug 2026
Director
Buy indirect
1,666,667
$18.00
$30.00M
Chimovits Erez
7 Aug 2026
Director
Buy indirect
273,333
$18.00
$4.92M
Chimovits Erez
7 Aug 2026
Director
Buy indirect
1,666,667
$18.00
$30.00M
AH Bio Fund IV, L.P.
7 Aug 2026
10% owner
Buy indirect
1,100,000
$18.00
$19.80M

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 51,940,638
History held since 7 Aug 2026